Justice Department Expands Civil Rights Probes to 15 Additional Medical Schools
The U.S. Department of Justice announced on June 4, 2026, that its Civil Rights Division has opened 15 new investigations into potential race discrimination in the admissions practices of medical schools across the country. Each of the targeted institutions receives millions of dollars in federal funding, placing them under Title VI of the Civil Rights Act of 1964, which prohibits discrimination on the basis of race, color, or national origin by recipients of federal financial assistance.
This development builds directly on earlier actions by the department. In March 2026, the DOJ launched compliance reviews at the medical schools of Stanford University, the University of California San Diego, and Ohio State University. Those reviews sought extensive applicant-level data, including MCAT scores, grade point averages, extracurricular activities, personal essays, demographic information, and internal policy documents. In May 2026, the department issued findings that the medical schools at the University of California Los Angeles and Yale University had illegally considered race in admissions decisions, violating the Supreme Court’s 2023 ruling in Students for Fair Admissions v. Harvard College.
Background on the Supreme Court Ruling and Title VI Enforcement
The 2023 Supreme Court decision ended the use of race as a factor in undergraduate and graduate admissions at colleges and universities that receive federal funding. The ruling clarified that such practices violate the Equal Protection Clause of the Fourteenth Amendment and, by extension, Title VI when federal dollars are involved. Medical schools, as graduate professional programs, fall squarely within the scope of this precedent.
Assistant Attorney General Harmeet Dhillon, who leads the Civil Rights Division, stated that the new investigations aim to ensure students become doctors based on merit rather than race. The department emphasized that the probes examine whether admissions processes comply with federal law as interpreted by the Court.
Scope of the New Investigations
The June 4 announcement did not name the 15 additional medical schools under review. Officials indicated that the investigations will mirror the earlier compliance reviews, requesting detailed admissions data spanning multiple years. Schools must provide records on applicant qualifications, decision-making processes, and any consideration of demographic factors. Failure to comply could jeopardize continued access to federal grants, research funding, and student aid programs.
Medical schools operate in a highly regulated environment. They must balance academic standards, clinical training requirements set by the Liaison Committee on Medical Education, and institutional missions that often include commitments to serving diverse patient populations. The DOJ actions focus narrowly on whether race has been used as a plus factor in ways prohibited by the Supreme Court.
Implications for University Administrators and Admissions Offices
University leaders and admissions directors now face heightened scrutiny of their policies and data practices. Many institutions have already revised their admissions criteria following the 2023 ruling, shifting emphasis to socioeconomic status, first-generation status, geographic diversity, and personal experiences. The new probes will test whether those revisions fully eliminated any residual consideration of race.
Administrators must prepare for extensive document production requests. Legal counsel at affected institutions are advising thorough internal audits of admissions rubrics, committee training materials, and communications that reference diversity goals. The process can strain staff resources, particularly at smaller or public medical schools with limited administrative capacity.
Photo by Quentin Schulz on Unsplash
Impact on Faculty Hiring and Research Funding
The investigations extend beyond student admissions to touch broader institutional practices. Medical school faculty often participate in admissions committees, and some research grants include expectations around workforce diversity. The DOJ focus on merit-based selection may influence how departments discuss diversity in hiring and promotion decisions.
Faculty members involved in graduate medical education could see changes in how they evaluate residency applicants or design outreach programs. Institutions that receive substantial National Institutes of Health funding may need to document that research training opportunities remain open to all qualified candidates without regard to race.
Perspectives from Medical Education Stakeholders
Representatives of medical schools have generally declined detailed comment while investigations remain active. Some deans have publicly reaffirmed their commitment to selecting students based on academic achievement, clinical potential, and character. Others note that holistic review has long incorporated multiple factors beyond test scores and grades.
Student advocacy groups and professional organizations such as the Association of American Medical Colleges continue to emphasize the importance of a physician workforce that reflects the demographic makeup of the patient population served. They argue that diverse medical school classes contribute to improved cultural competence and health outcomes in underserved communities.
Effects on Prospective Medical Students and PhD-Track Applicants
Applicants to medical school, including those pursuing combined MD-PhD programs, are watching the developments closely. The emphasis on merit may encourage stronger focus on MCAT preparation, research experience, and clinical shadowing. At the same time, students from underrepresented backgrounds may seek clearer guidance on how personal narratives and life experiences will be evaluated.
PhD-track job seekers in biomedical sciences who teach or advise undergraduates may find themselves fielding more questions about admissions trends and career pathways in medicine. Career services offices at universities are updating resources to help students navigate the evolving landscape.
Broader Higher Education Context and Compliance Strategies
The medical school probes fit into a larger pattern of federal enforcement across higher education. Similar reviews have occurred at undergraduate institutions, and the department has signaled continued attention to graduate and professional programs. Institutions that proactively align their policies with the Supreme Court decision may reduce their risk of investigation.
Recommended steps for compliance include rewriting any admissions guidance that references racial or ethnic goals, training committee members on permissible holistic factors, and maintaining detailed records demonstrating race-neutral decision making. External consultants specializing in higher education law are reporting increased demand for policy reviews.
Photo by Galt Museum & Archives on Unsplash
Future Outlook for Medical School Admissions
As the 2026-2027 admissions cycle approaches, medical schools will likely continue refining race-neutral approaches that still support institutional goals of excellence and service. Data from the first post-ruling cycles show shifts in applicant pools and matriculant demographics at some institutions, though long-term trends remain under study.
The DOJ has indicated that it will continue to monitor compliance and expand investigations where warranted. Medical schools that successfully demonstrate adherence to merit-based standards may serve as models for peers navigating the same requirements.
Resources for Higher Education Professionals
University administrators and faculty can find detailed guidance on the Department of Justice website regarding Title VI enforcement. The Supreme Court opinion in Students for Fair Admissions v. Harvard College remains the foundational legal document for policy development. Professional associations continue to host webinars and issue best-practice documents on compliant admissions practices.